Cargando…
A New Classification Method of Metastatic Cancers Using a (1)H-NMR-Based Approach: A Study Case of Melanoma, Breast, and Prostate Cancer Cell Lines
In this study, metastatic melanoma, breast, and prostate cancer cell lines were analyzed using a (1)H-NMR-based approach in order to investigate common features and differences of aggressive cancers metabolomes. For that purpose, (1)H-NMR spectra of both cellular extracts and culture media were comb...
Autores principales: | Schepkens, Corentin, Dallons, Matthieu, Dehairs, Jonas, Talebi, Ali, Jeandriens, Jérôme, Drossart, Lise-Marie, Auquier, Guillaume, Tagliatti, Vanessa, Swinnen, Johannes V., Colet, Jean-Marie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6918216/ https://www.ncbi.nlm.nih.gov/pubmed/31744229 http://dx.doi.org/10.3390/metabo9110281 |
Ejemplares similares
-
New Insights About Doxorubicin-Induced Toxicity to Cardiomyoblast-Derived H9C2 Cells and Dexrazoxane Cytoprotective Effect: Contribution of In Vitro
(1)H-NMR Metabonomics
por: Dallons, Matthieu, et al.
Publicado: (2020) -
GPR91 Receptor Mediates Protection against Doxorubicin-Induced Cardiotoxicity without Altering Its Anticancer Efficacy. An In Vitro Study on H9C2 Cardiomyoblasts and Breast Cancer-Derived MCF-7 Cells
por: Dallons, Matthieu, et al.
Publicado: (2020) -
A Comparative Study of Rat Urine (1)H-NMR Metabolome Changes Presumably Arising from Isoproterenol-Induced Heart Necrosis Versus Clarithromycin-Induced QT Interval Prolongation
por: Dallons, Matthieu, et al.
Publicado: (2020) -
Metabolic Reprogramming in Metastatic Melanoma with Acquired Resistance to Targeted Therapies: Integrative Metabolomic and Proteomic Analysis
por: Soumoy, Laura, et al.
Publicado: (2020) -
Targeting Metabolic Reprogramming to Improve Breast Cancer Treatment: An In Vitro Evaluation of Selected Metabolic Inhibitors Using a Metabolomic Approach
por: Draguet, Anaïs, et al.
Publicado: (2021)